Freshly unpacked: Report on the 2018/19 financial year
BRAIN AG has again combined its consolidated financial statements with a comprehensive insight into the activities of the past fiscal year.
The visual highlight of the approximately 200-page work entitled “Pioneering Bioproducts” is undoubtedly the photographs taken during an event celebrating the Bauhaus anniversary. Those interested in the company will also find plenty of overviews, insights and outlooks.
To stick with the outlook: For the 2019/20 financial year, the Management Board expects a positive business development with substantial organic revenue growth in both segments and a considerably improved, but still negative adjusted EBITDA. With a significantly improved earnings situation in both segments, the BioIndustrial segment is expected to post a further increasing positive adjusted EBITDA and the BioScience segment a continued negative adjusted EBITDA.
The annual report 2018/19 of BRAIN AG is available here.